Adam K. Stern - 07 Jan 2025 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role: Director
Signature: /s/ Adam Stern
Issuer symbol: DRIO
Transactions as of: 07 Jan 2025
Net transactions value: +$100,000
Form type: 4
Filing time: 10 Jan 2025, 16:04:16 UTC
Previous filing: 09 Aug 2024
Next filing: 10 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Shares After	Date	Ownership
holding	DRIO	Common Stock	194,341	07 Jan 2025	Direct
holding	DRIO	Common Stock	122,909	07 Jan 2025	AKS Family Partners L.P.
holding	DRIO	Series-C Preferred Stock	123,763	07 Jan 2025	AKS Family Partners L.P.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DRIO	Series D-2 Preferred Stock	Purchase	$100,000	+100		$1000.00	0	07 Jan 2025	Common Stock		$0.8300	AKS Family Partners L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.

Content

The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.